310 related articles for article (PubMed ID: 27720552)
1. Aqueous Chlorhexidine for Intravitreal Injection Antisepsis: A Case Series and Review of the Literature.
Merani R; McPherson ZE; Luckie AP; Gilhotra JS; Runciman J; Durkin S; Muecke J; Donaldson M; Aralar A; Rao A; Davies PE
Ophthalmology; 2016 Dec; 123(12):2588-2594. PubMed ID: 27720552
[TBL] [Abstract][Full Text] [Related]
2. Aqueous chlorhexidine (0.1%) is an effective alternative to povidone-iodine for intravitreal injection prophylaxis.
Oakley CL; Vote BJ
Acta Ophthalmol; 2016 Dec; 94(8):e808-e809. PubMed ID: 26947261
[No Abstract] [Full Text] [Related]
3. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
[TBL] [Abstract][Full Text] [Related]
4. Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept.
Forooghian F; Albiani DA; Kirker AW; Merkur AB
Can J Ophthalmol; 2017 Dec; 52(6):616-619. PubMed ID: 29217032
[TBL] [Abstract][Full Text] [Related]
5. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
[TBL] [Abstract][Full Text] [Related]
6. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Borkar DS; Obeid A; Su DC; Storey PP; Gao X; Regillo CD; Kaiser RS; Garg SJ; Hsu J;
Am J Ophthalmol; 2018 Oct; 194():1-6. PubMed ID: 29981738
[TBL] [Abstract][Full Text] [Related]
7. Endophthalmitis after Anti-VEGF Intravitreal Injections with Aqueous Chlorhexidine versus Povidone-Iodine as Ocular Antiseptics.
Ton NS; Goncharov V; Zapata I; Adam MK
Ophthalmol Retina; 2024 Jun; 8(6):521-526. PubMed ID: 38122867
[TBL] [Abstract][Full Text] [Related]
8. Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.
Souied EH; Dugel PU; Ferreira A; Hashmonay R; Lu J; Kelly SP
Ophthalmic Epidemiol; 2016; 23(2):71-9. PubMed ID: 26855278
[TBL] [Abstract][Full Text] [Related]
9. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
[TBL] [Abstract][Full Text] [Related]
10. LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.
Freiberg FJ; Brynskov T; Munk MR; Sørensen TL; Wolf S; Wirth MA; Becker M; Michels S
Retina; 2017 Dec; 37(12):2341-2346. PubMed ID: 28099318
[TBL] [Abstract][Full Text] [Related]
11. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).
Meredith TA; McCannel CA; Barr C; Doft BH; Peskin E; Maguire MG; Martin DF; Prenner JL;
Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198
[TBL] [Abstract][Full Text] [Related]
12. Aqueous Chlorhexidine Compared with Povidone-Iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial.
Ali FS; Jenkins TL; Boparai RS; Obeid A; Ryan ME; Wibblesman TD; Chiang A; Garg SJ;
Ophthalmol Retina; 2021 Aug; 5(8):788-796. PubMed ID: 33221515
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
Bhatt SS; Stepien KE; Joshi K
Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics.
Hsu J; Gerstenblith AT; Garg SJ; Vander JF
Am J Ophthalmol; 2014 Mar; 157(3):514-8.e1. PubMed ID: 24332373
[TBL] [Abstract][Full Text] [Related]
15. Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis.
Garg SJ; Dollin M; Hsu J; Storey P; Vander JF
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1028-34. PubMed ID: 26599245
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
[TBL] [Abstract][Full Text] [Related]
17. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
Li AL; Wykoff CC; Wang R; Chen E; Benz MS; Fish RH; Wong TP; Major JC; Brown DM; Schefler AC; Kim RY; OʼMalley RE
Retina; 2016 Jul; 36(7):1349-56. PubMed ID: 26655622
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S;
Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
[TBL] [Abstract][Full Text] [Related]
19. Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis.
Torres-Costa S; Ramos D; Brandão E; Carneiro Â; Rosas V; Rocha-Sousa A; Falcão-Reis F; Falcão M
Eur J Ophthalmol; 2021 Mar; 31(2):600-606. PubMed ID: 32019339
[TBL] [Abstract][Full Text] [Related]
20. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.
Gregori NZ; Flynn HW; Schwartz SG; Rosenfeld PJ; Vaziri K; Moshfeghi AA; Fortun JA; Kovach JL; Dubovy SR; Albini TA; Davis JL; Berrocal AM; Smiddy WE
Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):643-8. PubMed ID: 26114845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]